Numerous investigations have demonstrated that, in comparison to healthy donors, MM patients have considerably higher levels of Th17 cells in PBMCs and serum concentrations of Th17-associated cytokines, such as IL-1b, IL-6, IL-17, IL-21, IL-22, and IL-23 [31,32,33]. This evidence concerns the gene IL17A and Miyoshi myopathy.